"Avoidable Deaths" - Union for International Cancer Control
"Back to Basics: The Concept of HRQL Under a Magnifying Glass" - EORTC Quality of Life Group
"Bald for a Cause" initiative - UWC Dilijan College
Dhan Chand: BOT/BAL shows potential to overcome immunological "cold" tumors
Aleix Prat: ADCs in pretreated HER2-low metastatic breast cancer
Gate2Brain has reached a major milestone as its innovative drug, G2B-002, has received Orphan Drug Designation
Major Changes in NCI ACE Award: Removal of Citizenship Requirements and Eligibility Limitations
Rahul Banerjee: How do we standardize the standard of care for bortezomib (Velcade) in multiple myeloma?
CancerX Accelerator 2026 Applications Are Opening Soon
